Ylva Kaiser

536 total citations
10 papers, 370 citations indexed

About

Ylva Kaiser is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Ylva Kaiser has authored 10 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 4 papers in Immunology. Recurrent topics in Ylva Kaiser's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Occupational exposure and asthma (2 papers). Ylva Kaiser is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Sarcoidosis and Beryllium Toxicity Research (8 papers) and Occupational exposure and asthma (2 papers). Ylva Kaiser collaborates with scholars based in Sweden, United States and Netherlands. Ylva Kaiser's co-authors include Johan Grünewald, Anders Eklúnd, Susanna Kullberg, Junting Ai, Marcus R. Clark, Anna Smed‐Sörensen, Don Wolfgeher, Rico Lepzien, Mikael C. I. Karlsson and Tracy L. McGaha and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Frontiers in Immunology.

In The Last Decade

Ylva Kaiser

10 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ylva Kaiser Sweden	10	257	233	95	75	68	10	370
Leontine Mulder Netherlands	6	164 0.6×	204 0.9×	161 1.7×	68 0.9×	56 0.8×	7	396
Laura S. Christian United States	4	185 0.7×	133 0.6×	158 1.7×	26 0.3×	57 0.8×	5	343
Cecilia Vagaggini Italy	6	99 0.4×	175 0.8×	68 0.7×	26 0.3×	61 0.9×	6	297
Yohei Yatagai Japan	11	183 0.7×	212 0.9×	71 0.7×	66 0.9×	39 0.6×	27	354
Kenjiro Shima Japan	13	91 0.4×	182 0.8×	136 1.4×	112 1.5×	60 0.9×	29	453
Yasushi Miyake Japan	9	119 0.5×	143 0.6×	78 0.8×	31 0.4×	40 0.6×	11	302
Connie S. Floerchinger United States	7	200 0.8×	282 1.2×	31 0.3×	48 0.6×	72 1.1×	7	395
Rico Lepzien Sweden	7	105 0.4×	127 0.5×	158 1.7×	46 0.6×	82 1.2×	11	313
Adrian J. Baatjes Canada	14	449 1.7×	185 0.8×	250 2.6×	17 0.2×	65 1.0×	23	599
C. R. Austin United States	9	135 0.5×	93 0.4×	61 0.6×	55 0.7×	51 0.8×	11	286

Countries citing papers authored by Ylva Kaiser

Since Specialization

Citations

This map shows the geographic impact of Ylva Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ylva Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ylva Kaiser more than expected).

Fields of papers citing papers by Ylva Kaiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ylva Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ylva Kaiser. The network helps show where Ylva Kaiser may publish in the future.

Co-authorship network of co-authors of Ylva Kaiser

This figure shows the co-authorship network connecting the top 25 collaborators of Ylva Kaiser. A scholar is included among the top collaborators of Ylva Kaiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ylva Kaiser. Ylva Kaiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kaiser, Ylva, Anders Eklúnd, & Johan Grünewald. (2019). Moving target: shifting the focus to pulmonary sarcoidosis as an autoimmune spectrum disorder. European Respiratory Journal. 54(1). 1802153–1802153. 38 indexed citations

Miedema, Jelle, Ylva Kaiser, Caroline E. Broos, et al.. (2018). Th17-lineage cells in pulmonary sarcoidosis and Löfgren's syndrome: Friend or foe?. Journal of Autoimmunity. 87. 82–96. 36 indexed citations

Kaiser, Ylva, Don Wolfgeher, Junting Ai, et al.. (2018). In Situ Humoral Immunity to Vimentin in HLA-DRB1*03+ Patients With Pulmonary Sarcoidosis. Frontiers in Immunology. 9. 1516–1516. 61 indexed citations

Kaiser, Ylva, Tadepally Lakshmikanth, Yang Chen, et al.. (2017). Mass Cytometry Identifies Distinct Lung CD4+ T Cell Patterns in Löfgren’s Syndrome and Non-Löfgren’s Syndrome Sarcoidosis. Frontiers in Immunology. 8. 1130–1130. 22 indexed citations

Kaiser, Ylva, et al.. (2017). Löfgren's Syndrome: Diagnosis, Management, and Disease Pathogenesis. Seminars in Respiratory and Critical Care Medicine. 38(4). 463–476. 24 indexed citations

Mitchell, Angela M., Ylva Kaiser, Michael T. Falta, et al.. (2017). Shared αβ TCR Usage in Lungs of Sarcoidosis Patients with Löfgren’s Syndrome. The Journal of Immunology. 199(7). 2279–2290. 17 indexed citations

Duhlin, Amanda, Yunying Chen, Fredrik Wermeling, et al.. (2016). Selective Memory to Apoptotic Cell–Derived Self-Antigens with Implications for Systemic Lupus Erythematosus Development. The Journal of Immunology. 197(7). 2618–2626. 13 indexed citations

Kaiser, Ylva, Rico Lepzien, Susanna Kullberg, et al.. (2016). Expanded lung T-bet⁺RORγT⁺CD4⁺T-cells in sarcoidosis patients with a favourable disease phenotype. European Respiratory Journal. 48(2). 484–494. 55 indexed citations

Grünewald, Johan, Ylva Kaiser, Mahyar Ostadkarampour, et al.. (2015). T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis. European Respiratory Journal. 47(3). 898–909. 55 indexed citations

10.

Enoksson, Sara Lind, Emilie K. Grasset, Thomas Hägglöf, et al.. (2011). The inflammatory cytokine IL-18 induces self-reactive innate antibody responses regulated by natural killer T cells. Proceedings of the National Academy of Sciences. 108(51). E1399–407. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact